Purpose: To develop a high resolution microarray based method to detect single- and multiexons gene deletions and duplications. Methods: We have developed a high-resolution comparative genomic ...

The introduction of array comparative genome hybridization (CGH) into prenatal genetic diagnosis presents both challenges and controversy to the clinical cytogenetic community. The challenges are ...

In addition to the surprising revelation that our chromosomes harbor fewer genes than originally predicted, the Human Genome Project also unveiled that all individuals share approximately 99.9% of ...

Comparative genomic hybridization (CGH) was developed to identify pathogenic DNA copy-number changes (e.g., duplications, deletions) on a genome-wide scale, and to map these changes to genomic ...

計測機器大手Agilent Technologiesの日本法人であるアジレント・テクノロジーは2月12日、ベイラー医科大学 遺伝医学研究所と ...

Roche NimbleGen, Inc. has launched NimbleGen Comparative Genomic Hybridization (CGH) microarrays in a 12x135K format for analysis of DNA copy number variation. NimbleGen CGH 12x135K arrays will allow ...

Background: To apply high throughput technologies (CGH array, Hot Spot Mutations arrays) in daily practice in order to drive patients to tailored targeted therapies. Methods: High resolution ...

平成26年4月から開始した、幹細胞評価基盤技術研究組合（理事長：吉岡 康弘 富士フイルム（株）フェロー） *1 の受託事業プロジェクト「再生医療の産業化に向けた細胞製造・加工システムの開発」（委託元は、平成26年度：独立行政法人 新 ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced that scientists using the company’s comparative genomic hybridization (CGH) technology have shown that cancer ...

オリゴヌクレオチドマイクロアレイを遺伝子発現研究だけに用いる時代は過ぎ去った。むしろ、例えば遺伝子型判定でマイクロアレイの果たす機能などの方が、もともとの用途よりも重要な意味を持つようになったといえるのではないだろうか。最近発表さ ...

Predictive markers of everolimus efficacy in hormone receptor positive (HR+) metastatic breast cancer (MBC): Final results of the TAMRAD trial translational study. This is an ASCO Meeting Abstract ...